Effects of Icariside Ⅱ on intracavernosal pressure and mean systematic arterial blood pressure of rat and its mechanism

Jian Zhang,Tao Liu,Xincheng Qin,Weiren Li,Wanshou Cui,Yanqing Gong,Zhongcheng Xin

DOI: https://doi.org/10.3969/j.issn.1008-0848.2010.01.003

2010-01-01

Abstract:Objective To realize the effect of Icariside Ⅱ isolated from natural herbal medicine on erectile dysfunction, intracavernosal pressure (ICP) and mean arterial pressure(MAP) including its mechanism was investigated in in vivo study. Methods The rat corpora cavernosa (CC) and left carotid artery were isolated unilaterally, a 26G needle catheter was inserted into the left CC to monitor the intracavernosal pressure (ICP) and administrate drug.Another catheter was placed into the carotid artery to monitor MAP. Rat cavernous nerve (CN) was identified for electric stimulation. Different concentrations of Icariside Ⅱ were administrated intracavernosally, ICP and MAP were recorded during electric stimulation on CN. Icariin, Sildenafil and Papavreine were used as positive controls. The effects of soluble guanylate cyclase inhibitor H-[1,2,4] oxadiazole[4,3,-A] quinoxalin-1-one (ODQ), nitric oxide formation inhibitor methylene blue (MB) and nitric oxide syntheses (NOS) inhibitor N~ω-nitro-L-arginine (LNNA) on Icariside Ⅱ (10~(-4)mol/L) induced ICP MAP changes were also investigated. Results All four kinds of drugs increased the ICP in a dose-depended manner (P<0.01), and Icariside Ⅱ, Icariin, Sildenafil did not significanly influence on MAP (P>0.05).However, Papavreine at the concentration of 10~(-4) mol/L significantly reduced MAP (P<0.01). ODQ, MB and LNNA significantly inhibited ICP induced by Icariside Ⅱ and Icariin (P<0.01), however, the effect of Sildenafil was not significanly influenced by the above three inhibitors. (P>0.05). Conclusion Both of Icariside Ⅱ and Icariin can enhance erectile function(ICP) without infuluence on MAP by specific activation on NO-cGMP signal pathway in CC.